Jamal A Ibdah Selected Research

Weight Loss (Weight Reduction)

8/2017	Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.
10/2015	Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.
1/2006	Nonalcoholic steatohepatitis and the cardiometabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jamal A Ibdah Research Topics

Disease

24	Non-alcoholic Fatty Liver Disease 02/2024 - 01/2006
10	Liver Diseases (Liver Disease) 04/2024 - 09/2002
9	Fibrosis (Cirrhosis) 02/2024 - 09/2008
9	Insulin Resistance 08/2017 - 05/2005
8	Obesity 02/2024 - 10/2010
8	Inflammation (Inflammations) 02/2024 - 03/2008
7	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 10/2008
6	Type 2 Diabetes Mellitus (MODY) 10/2015 - 06/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2013
5	Body Weight (Weight, Body) 01/2018 - 09/2008
4	Acute fatty liver of pregnancy 01/2018 - 11/2002
4	Hemolysis 11/2013 - 09/2002
3	Fatty Liver 12/2023 - 01/2009
3	Pain (Aches) 05/2023 - 02/2017
3	Weight Loss (Weight Reduction) 08/2017 - 01/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 05/2023 - 07/2021
2	Hemorrhage 09/2018 - 08/2016
2	Neoplasms (Cancer) 08/2014 - 04/2012
2	Pre-Eclampsia (Preeclampsia) 11/2013 - 09/2002
2	Hyperemesis Gravidarum 11/2013 - 01/2005
2	HELLP Syndrome 01/2005 - 11/2002
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Carcinogenesis 01/2020
1	Ulcer 09/2018
1	Deglutition Disorders (Dysphagia) 09/2018
1	Pathologic Constriction (Stenosis) 09/2018
1	Trifunctional Protein Deficiency With Myopathy And Neuropathy 01/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2017
1	Infections 07/2017
1	Hyperbilirubinemia 02/2017
1	Hepatitis 02/2017
1	Jaundice (Icterus) 02/2017
1	Fatigue 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Metabolic Diseases (Metabolic Disease) 12/2016

Drug/Important Bio-Agent (IBA)

18	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 01/2005
12	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2008
12	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2005
10	Triglycerides (Triacylglycerol)IBA 12/2023 - 03/2008
10	Insulin (Novolin)FDA Link 01/2018 - 05/2005
7	LipidsIBA 02/2024 - 01/2008
7	Mitochondrial Trifunctional ProteinIBA 01/2018 - 09/2002
6	EnzymesIBA 10/2015 - 09/2002
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2014
4	Messenger RNA (mRNA)IBA 02/2024 - 06/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2013 - 01/2005
3	CollagenIBA 01/2016 - 05/2011
2	Indicators and Reagents (Reagents)IBA 05/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 02/2022 - 10/2010
2	Alkaline PhosphataseIBA 02/2022 - 07/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2013
2	Alanine Transaminase (SGPT)IBA 07/2021 - 03/2015
2	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 01/2020 - 12/2007
2	Transaminases (Aminotransferases)IBA 02/2017 - 01/2005
2	SirtuinsIBA 12/2016 - 05/2014
2	CholesterolIBA 01/2016 - 06/2013
2	Nonesterified Fatty Acids (NEFA)IBA 11/2015 - 03/2008
2	Ethanol (Ethyl Alcohol)IBA 11/2015 - 11/2015
2	Metformin (Glucophage)FDA LinkGeneric 10/2015 - 02/2014
2	DiglyceridesIBA 06/2013 - 05/2011
2	Phosphotransferases (Kinase)IBA 06/2013 - 01/2008
2	Cytochromes c (Cytochrome c)IBA 06/2010 - 05/2010
2	PPAR deltaIBA 06/2010 - 04/2010
2	PPAR gammaIBA 04/2010 - 09/2008
2	Angiotensin IIIBA 01/2009 - 09/2008
1	hemoglobin ASIBA 04/2024
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 04/2024
1	LyasesIBA 04/2024
1	PalmitatesIBA 02/2024
1	nasIBA 02/2024
1	Thyroid HormonesIBA 12/2023
1	AcidsIBA 12/2023
1	IsotopesIBA 12/2023
1	VLDL LipoproteinsIBA 12/2023
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2021
1	CarbohydratesIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	NAD (NADH)IBA 01/2018
1	Sirtuin 3IBA 01/2018
1	Phospholipases (Phospholipase)IBA 08/2017
1	VaccinesIBA 07/2017
1	Coffee FDA Link 05/2017
1	velpatasvirIBA 01/2017
1	SofosbuvirIBA 01/2017
1	Nifedipine (Adalat)FDA LinkGeneric 01/2017
1	TabletsIBA 01/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 08/2016
1	Sucrose (Saccharose)IBA 01/2016
1	InterleukinsIBA 01/2016

Therapy/Procedure

12	Therapeutics 12/2023 - 01/2006
5	Caloric Restriction 10/2015 - 10/2010
2	Length of Stay 05/2023 - 06/2020
2	Bariatric Surgery 11/2022 - 07/2021
2	Fecal Microbiota Transplantation 01/2018 - 11/2016
2	Diet Therapy (Therapy, Diet) 08/2017 - 05/2011
1	Ligation 09/2018
1	Endoscopic Hemostasis 08/2016
1	Surgical Instruments (Clip) 08/2016